<PAGE> 1
Filed By Eclipsys Corporation
Pursuant to Rule 425 under the
Securities Act of 1933
And deemed filed pursuant to Rule 14a-12 under the
Securities Exchange Act of 1934
Subject Companies: Neoforma.com, Inc., Eclipsys, Inc.
HEALTHvision, Inc.
Commission File No.: 000-28715
Press Release
[ECLIPSYS LOGO]
ECLIPSYS STOCKHOLDER LAWSUITS FILED; EARNINGS RELEASED NEXT WEEK
DELRAY BEACH, FL -- APRIL 20, 2000 -- Eclipsys(R) Corporation (NASDAQ: ECLP),
the leading provider of end-to-end information solutions that enable healthcare
enterprises to balance and improve clinical, financial and satisfaction
outcomes, has received two lawsuits filed in Delaware Chancery Court seeking to
enjoin or rescind the proposed transaction with Neoforma.com or to collect an
unspecified amount of damages. The shareholder suits in general allege that the
directors have breached their fiduciary duties and that the consideration
received by Eclipsys' shareholders would be inadequate. Eclipsys believes that
its directors have properly exercised their fiduciary duties and intends to
defend these claims vigorously.
Eclipsys expects to announce its financial results from the first quarter of
2000 on Monday, April 24 after the close of business. Given the pending
transaction with Neoforma.com and the related events, Eclipsys is canceling
Tuesday's Q1 conference call.
Eclipsys Corporation (www.eclipsys.com) delivers end-to-end information
solutions that enable healthcare enterprises to achieve balanced and improved
clinical, financial and satisfaction outcomes. Solutions include its
comprehensive, knowledge-based Sunrise software line; leading-edge integration
solutions; application services provider (ASP) information-management solutions;
business process reengineering; network design and implementation; and full IT
outsourcing. In conjunction with its HEALTHvision affiliate (see
www.healthvision.com), Eclipsys provides customized, locally branded Web-based
solutions to healthcare delivery systems. Eclipsys has more than 1,400 customer
organizations throughout the U.S. and in 17 other countries. For more
information, contact Investor Relations at [email protected] or by
calling (561) 266-2324.
Statements in this news release concerning future results, performance or
expectations are forward-looking statements. Because such statements involve
risks and uncertainties, actual results may differ materially from those
expressed or implied by such forward-looking statements. These risks included
risks relating to merger discussions and possible integration of the combined
businesses and their products uncertainties regarding future financial results
and other risks described in the filings of Eclipsys with the Securities and
Exchange Commission. Eclipsys, Eclipsys Corporation and The Outcomes Company
are registered trademarks and Sunrise is a trademark of Eclipsys Solutions Corp.
Other product and company names in this news release are trademarks or
registered trademarks of their respective companies.
Contact:
Eclipsys:
Randy L. Thomas, Corporate Strategy and Marketing (media)
(561) 266-2348 - [email protected]
Greg Wilson, CFO (investors)
(561) 266-2324 - [email protected]
